b-cells

Documents about b-cells

• Multiplex engineering of rhesus macaque NK cells enhances homing to sites of HIV replication in B cell follicles.#356377bioRxiv / medRxiv
• CD24 and CD27 resolve ontogeny and gradual differentiation of CD11c+ atypical memory B cells after malaria infection#424110bioRxiv / medRxiv
• DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.#818581HAL Science
• The Value of Memory B Cells Marker (CD27) and Howell Jelly Bodies Detrection in Critically Ill Patients#827830ClinicalTrials.gov
• Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells#181761ClinicalTrials.gov
• The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies#287558ClinicalTrials.gov
• Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies#832346ClinicalTrials.gov
• A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies#898600ClinicalTrials.gov
• CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.#843826ClinicalTrials.gov
• CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)#861685ClinicalTrials.gov
• Investigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion.#800627ClinicalTrials.gov
• Extracellular vesicles from wild-type Epstein-Barr virus-transformed B-cells export host DNA and the viral lncRNA EBER1#146509bioRxiv / medRxiv
• OCA-B/Pou2af1 Expression in T Cells Promotes PD-1 Blockade-Induced Autoimmunity but is Dispensable for Anti-Tumor Immunity#189362bioRxiv / medRxiv
• A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia#405159ClinicalTrials.gov
• Identification of pre-existing ubiquitous neoantigen-reactive tumor-infiltrating T-cells in a patient with metastatic pancreatic neuroendocrine tumor#633101bioRxiv / medRxiv
• A Clinical Study of CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases#880917ClinicalTrials.gov
• Dataset for "<b>Transient NMDAR-CaMKII signalling resolves competition among dendritic trees to establish Purkinje cell architecture</b>"#391584Figshare
• Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma#848371ClinicalTrials.gov
• Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma#895353ClinicalTrials.gov
• Generation of human monoclonal autoantibodies from rare myelin oligodendrocyte glycoprotein-specific patient-derived B cells using an optofluidic-based platform#228125Ora Oxford University Research
• Multiplexed single-cell and spatial profiling reveal B cells and tertiary lymphoid structures as prognostic indicators in pleural mesothelioma.#323071NCBI PubMed Central
• Implications of cytokines in Memory B cell for risk stratification and therapeutic framework construction among Pediatric Influenza patents: insights from machine learning and multi-omics.#275963PubMed
• B-Cell involvement in immune checkpoint inhibitor-induced lichen planus: A comparative analysis with non–drug-related lichen planus#471876HAL (France)
• To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL#824946ClinicalTrials.gov
• Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response#910540ClinicalTrials.gov
• CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma#230391ClinicalTrials.gov
• A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies#851619ClinicalTrials.gov
• Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL#217015ClinicalTrials.gov
• Surface functionalization of small extracellular vesicles derived from Caco-2 and HEK293T cells in the neutralization of Shiga toxin 1 subunit B#398134bioRxiv / medRxiv
• Notch2 signaling instructs viral and bacterial TLR responsiveness in B cells#484997Europe PMC
• ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma#870827ClinicalTrials.gov
• A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma#628547ClinicalTrials.gov
• Infusion of Allogeneic, 3rd Party CD19-specific T Cells#874036ClinicalTrials.gov
• Btk Regulates B Cell Receptor-Mediated Antigen Processing And Presentation By Controlling Actin Cytoskeleton Dynamics In B Cells#412856OpenCitations
• Coordinate regulation of the senescent state by selective autophagy#389934S-Space: Seoul National University
• Myasthenia thymus reprograms class-switched B cells into BAFF-dependent survivors#484942Europe PMC
• A theoretical study of methanol oxidation mechanisms by methanol dehydrogenase enzymes for fuel cell applications#958032Louisiana Tech Digital Commons
• Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma#860629ClinicalTrials.gov
• Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell#804696ClinicalTrials.gov
• AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas#810294ClinicalTrials.gov
• Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia#863671ClinicalTrials.gov
• Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19#979684ClinicalTrials.gov
• CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma#992861ClinicalTrials.gov
• Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood#889881ClinicalTrials.gov
• Aurora kinase A enables collective invasion and metastasis by endowing a leader cell phenotype and stabilizing Eplin-mediated cohesion with follower cells#148825bioRxiv / medRxiv
• Early Assessment of Cardiac Function After Treatment With CAR-T Cells#230421ClinicalTrials.gov
• C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)#267996ClinicalTrials.gov
• An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).#886294ClinicalTrials.gov
• T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL#969610ClinicalTrials.gov
• DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease#934588Koc University Digital Collections